Relationship between RAD51-G135C and XRCC3-C241T Single Nucleotide Polymorphisms and Onset of Acute Myeloid Leukemia.
- Author:
Lei MIAO
1
;
Xi-Feng QIAN
2
;
Guo-Hua YANG
2
;
Li-Dong ZHAO
3
Author Information
- Publication Type:Journal Article
- MeSH: DNA-Binding Proteins; Heterozygote; Homozygote; Humans; Leukemia, Myeloid, Acute; Polymorphism, Single Nucleotide; Rad51 Recombinase
- From: Journal of Experimental Hematology 2015;23(3):605-611
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the relationship between RAD51-G135C and XRCC3-C241T single nucleotide polymorphisms and onset of acute myeloid leukemia (AML).
METHODSThe study was performed in 2 groups: AML patient group and normal person group as control group. Genomic DNA was extracted from peripheral blood cells of 545 AML patients and 1 034 normal persons. Genotypes of RAD51-G135C and XRCC3-C241T were analyzed by TaqMan probe technology and the ralatienship between RAD51-G135C/XRCC3-C241T polymorphisms and onset of acute myeloid leukemia was investigated.
RESULTSCompared with the control group, RAD51-G135C homozygous mutant (CC) could significantly increase the risk of AML patients (OR=3.07), and there was no statistical relationship between heterozygous mutant (GC) of RAD51-G135C and onset of AML. There was no statistical relationship between homozygous mutant (TT) of XRCC3-C241T and onset of AML, and the XRCC3-C241T heterozygous mutation type (CT) increased the risk of AML patients (OR=0.66).
CONCLUSIONRAD51-G135C homozygous mutant and XRCC3-C241T heterozygous mutation significantly increase the risk of the AML onset, which can provide more predictive value for incidence of AML.